Data / Research funding / Pennsylvania / Thomas Jefferson University
Thomas Jefferson University: 338 NIH awards ($373.2M) and 4 NSF awards ($1.3M), fiscal years 2021 to 2026
Thomas Jefferson University in Philadelphia, PA is funded under 338 NIH awards ($373.2M) and 4 NSF awards ($1.3M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- R8JEVL4ULGB7
- State
- Pennsylvania
Awards
342 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Translational Research in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,323,389 | June 22, 1995 | May 31, 2029 | CHAPMAN, ANDREW | reporter.nih.gov |
| Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,931,387 | September 1, 2017 | January 31, 2027 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| tRNA in codon usage | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,063,701 | March 1, 2020 | August 31, 2029 | HOU, YA-MING | reporter.nih.gov |
| TrmD-targeting actinobacterial natural products as next generation antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,187,325 | June 25, 2021 | May 31, 2027 | HOU, YA-MING | reporter.nih.gov |
| Clinical Pharmacology Training Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,914,786 | July 1, 1995 | June 30, 2030 | KRAFT, WALTER K | reporter.nih.gov |
| Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,177,343 | July 8, 2021 | June 30, 2027 | YANG, HUSHAN | reporter.nih.gov |
| Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,145,040 | August 25, 2022 | July 31, 2026 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL) | NIH | National Cancer Institute | 2021 to 2025 | $3,113,868 | July 1, 2021 | June 30, 2027 | CALABRETTA, BRUNO | reporter.nih.gov |
| TJU-JNMC Global Network for Women's and Children's Health Research Unit | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,034,594 | July 1, 2013 | July 31, 2030 | DERMAN, RICHARD J | reporter.nih.gov |
| Pyrimidine metabolism in the development of autoreactive B cells and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,989,958 | September 1, 2025 | August 31, 2029 | RAHMAN, ZIAUR | reporter.nih.gov |
| Targeting cell senescence in a novel model of spontaneous disc degeneration | NIH | National Institute on Aging | 2021 to 2025 | $2,972,378 | September 1, 2021 | May 31, 2027 | RISBUD, MAKARAND V | reporter.nih.gov |
| Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,943,903 | September 30, 2009 | July 31, 2027 | SRIVASTAVA, ANKITA | reporter.nih.gov |
| Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial | NIH | National Institute on Aging | 2021 to 2024 | $2,834,493 | February 15, 2020 | January 31, 2025 | ROVNER, BARRY W. | reporter.nih.gov |
| Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,805,290 | August 1, 2021 | July 31, 2025 | SUN, JIANXIN | reporter.nih.gov |
| Chromatin Biology of the African Trypanosome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,795,048 | June 1, 2025 | May 31, 2027 | DEBLER, ERIK | reporter.nih.gov |
| Molecular Mechanisms of Mitochondrial Transcription and Replication | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,688,940 | June 1, 2019 | May 31, 2029 | TEMIAKOV, DMITRY | reporter.nih.gov |
| Caspase-1 Activation by the Inflammasomes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,655,623 | May 15, 2021 | April 30, 2027 | ALNEMRI, EMAD S | reporter.nih.gov |
| ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,653,887 | April 1, 2021 | January 31, 2027 | HAJNOCZKY, GYORGY | reporter.nih.gov |
| Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,623,263 | February 1, 2020 | November 30, 2026 | FREEMAN, THERESA A | reporter.nih.gov |
| Regulatory role of PI3K signaling pathways in lens differentiation and function | NIH | National Eye Institute | 2021 to 2025 | $2,568,508 | December 1, 2015 | April 30, 2030 | MENKO, A. SUE | reporter.nih.gov |
| Provider Support and Patient Outreach in Lung Cancer Screening | NIH | National Cancer Institute | 2022 to 2025 | $2,561,580 | July 1, 2022 | June 30, 2027 | MYERS, RONALD E. | reporter.nih.gov |
| Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,557,384 | April 12, 2021 | March 31, 2026 | JUON, HEE-SOON | reporter.nih.gov |
| mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia | NIH | National Institute of Mental Health | 2021 to 2024 | $2,475,825 | May 6, 2019 | November 30, 2025 | HAHN, CHANG-GYU | reporter.nih.gov |
| Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators | NIH | National Cancer Institute | 2021 to 2024 | $2,461,554 | January 13, 2020 | December 31, 2025 | KIM, FELIX JINHYUN | reporter.nih.gov |
| Exploiting emerging ideas in G protein-coupled receptor biology and pharmacology to treat asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,456,717 | September 20, 2025 | July 31, 2030 | PENN, RAYMOND B. | reporter.nih.gov |
| Respiratory interneuron circuit plasticity: promoting recovery of diaphragm function after spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,455,409 | March 1, 2013 | April 30, 2028 | LEPORE, ANGELO C. | reporter.nih.gov |
| Monodisperse Microbubbles for Noninvasive Pressure Estimation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,377,071 | August 5, 2022 | April 30, 2027 | EISENBREY, JOHN | reporter.nih.gov |
| Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,342,707 | April 1, 2013 | April 30, 2026 | FORSBERG, FLEMMING | reporter.nih.gov |
| Mechanisms of cell death in cutaneous melanoma | NIH | National Cancer Institute | 2021 to 2025 | $2,341,029 | June 15, 2021 | May 31, 2027 | APLIN, ANDREW ERIC | reporter.nih.gov |
| Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,321,414 | September 1, 2020 | May 31, 2026 | THAKUR, MATHEW LAXMAN | reporter.nih.gov |
| Prostate Cancer Diagnosis by Multiparametric Ultrasound | NIH | National Cancer Institute | 2021 to 2024 | $2,294,658 | July 1, 2020 | June 30, 2025 | FORSBERG, FLEMMING | reporter.nih.gov |
| Molecular Neurogenetics of the Brainstem Neuronal Source of Cardioprotective Vagal Outflow | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,273,130 | July 1, 2022 | June 30, 2027 | SCHWABER, JAMES | reporter.nih.gov |
| Paradigms of maintaining anterior segment homeostasis | NIH | National Eye Institute | 2021 to 2025 | $2,254,974 | September 30, 2011 | March 31, 2028 | MENKO, A. SUE | reporter.nih.gov |
| Exploring the EphB2-NMDA receptor interaction in spinal cord injury-induced neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,249,630 | September 1, 2018 | June 30, 2029 | LEPORE, ANGELO C. | reporter.nih.gov |
| G Protein-Coupled Receptor Regulation in Airway Myocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,231,563 | August 1, 1997 | July 31, 2028 | PENN, RAYMOND B. | reporter.nih.gov |
| Monitoring neoadjuvant chemotherapy of breast cancer using 3D subharmonic aided pressure estimation | NIH | National Cancer Institute | 2021 to 2025 | $2,200,983 | July 1, 2019 | May 31, 2026 | NAM, KIBO | reporter.nih.gov |
| Promoting regenerative repair of aged cartilage | NIH | National Institute on Aging | 2023 to 2025 | $2,189,662 | May 15, 2023 | January 31, 2028 | COLLINS, JOHN A | reporter.nih.gov |
| Local immune tolerance in the large intestine mediated by GPR15 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,187,932 | February 21, 2020 | January 31, 2026 | KIM, SANGWON VINCENT | reporter.nih.gov |
| MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | NIH | National Cancer Institute | 2022 to 2025 | $2,185,830 | April 1, 2022 | March 31, 2027 | HE, JUN | reporter.nih.gov |
| Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,178,911 | December 1, 2014 | November 30, 2026 | CSORDAS, GYORGY | reporter.nih.gov |
| T cell control of MCMV and tissue-localized immune suppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,154,950 | March 11, 2020 | February 28, 2026 | SNYDER, CHRISTOPHER M | reporter.nih.gov |
| Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,154,714 | December 15, 2020 | November 30, 2026 | MA, LE | reporter.nih.gov |
| Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,140,211 | June 1, 2023 | May 31, 2028 | SIGAL, LUIS J | reporter.nih.gov |
| A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | NIH | National Cancer Institute | 2022 to 2025 | $2,123,519 | January 1, 2022 | December 31, 2026 | CALABRETTA, BRUNO | reporter.nih.gov |
| Sidney Kimmel Cancer Center LAPS Institutional Collaboration | NIH | National Cancer Institute | 2021 to 2025 | $2,117,629 | March 5, 2019 | February 28, 2026 | JOHNSON, JENNIFER | reporter.nih.gov |
| Prevention of anthracycline-induced cardiotoxicity by Nur77 activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,093,043 | July 16, 2021 | June 30, 2025 | SUN, JIANXIN | reporter.nih.gov |
| Development of an MRI Template & Neuroimaging Biomarkers of the Pediatric Spinal Cord | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,087,756 | March 15, 2020 | January 31, 2026 | MOHAMED, FEROZE B | reporter.nih.gov |
| METTL3 in chromium-induced angiogenesis and carcinogenesis | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,077,900 | April 29, 2022 | January 31, 2027 | MCMAHON, STEVEN B. | reporter.nih.gov |
| Early Life Environment Modifies Behavioral, Epigenetic, and Transcriptional Outcomes from Developmental Lead Exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,064,068 | August 14, 2020 | May 31, 2026 | SCHNEIDER, JAY S | reporter.nih.gov |
| Targeting visceral pain through intestinal neuropod cell GUCY2C signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,058,142 | September 19, 2023 | July 31, 2028 | WALDMAN, SCOTT A. | reporter.nih.gov |
| Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,017,956 | January 1, 2020 | December 31, 2025 | SYKULEV, YURI | reporter.nih.gov |
| The joint environment and periprosthetic joint infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,980,499 | August 4, 2023 | June 30, 2028 | HICKOK, NOREEN J | reporter.nih.gov |
| A New Cryo-Transmission Electron Microscope at Thomas Jefferson University | NIH | Office of the Director, National Institutes of Health | 2022 | $1,969,275 | July 1, 2022 | June 30, 2023 | CINGOLANI, GINO | reporter.nih.gov |
| Mitochondrial translocator protein: a target for bronchodilation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,957,445 | July 1, 2021 | June 30, 2027 | NAYAK, AJAY | reporter.nih.gov |
| Molecular mechanisms of triplet repeat instability in Huntington's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,938,300 | July 1, 2021 | June 30, 2027 | PLUCIENNIK, ANNA | reporter.nih.gov |
| A pragmatic randomized controlled trial assessing the impact of medically tailored meals and medical nutrition therapy via telehealth among patients with poorly controlled diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,913,610 | July 18, 2019 | June 30, 2025 | RISING, KRISTIN LAURA | reporter.nih.gov |
| Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,887,371 | May 29, 2021 | December 31, 2026 | VINOGRADSKIY, YEVGENIY | reporter.nih.gov |
| Mechanisms of uveal melanoma dormancy and targeted therapy tolerance | NIH | National Cancer Institute | 2021 to 2024 | $1,885,641 | September 1, 2020 | May 31, 2026 | APLIN, ANDREW ERIC | reporter.nih.gov |
| Retrieval Practice Principles: A Theory of Learning for Aphasia Rehabilitaion | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $1,850,265 | April 1, 2017 | August 31, 2028 | MIDDLETON, ERICA LEE | reporter.nih.gov |
| A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors | NIH | National Cancer Institute | 2021 to 2023 | $1,847,981 | June 11, 2019 | May 31, 2025 | WEN, KUANG-YI | reporter.nih.gov |
| Mitochondrial Calcium and Neuronal Health | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,838,079 | June 15, 2023 | May 31, 2028 | HAJNOCZKY, GYORGY | reporter.nih.gov |
| Multi-modality detection of RCC Recurrence Post Ablation | NIH | National Cancer Institute | 2023 to 2025 | $1,836,160 | December 1, 2022 | November 30, 2027 | EISENBREY, JOHN | reporter.nih.gov |
| From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,802,050 | July 1, 2022 | April 30, 2027 | TIGANO, MARCO | reporter.nih.gov |
| tRNA-derived non-coding RNAs in ASM function and in asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,764,249 | July 1, 2020 | June 30, 2025 | KIRINO, YOHEI | reporter.nih.gov |
| Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,760,000 | September 1, 2020 | June 30, 2025 | GUO, LIN | reporter.nih.gov |
| Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | NIH | National Cancer Institute | 2021 to 2025 | $1,759,271 | December 11, 2019 | November 30, 2026 | MARTINEZ OUTSCHOORN, UBALDO | reporter.nih.gov |
| Diacylglycerol kinase in airway smooth muscle functions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,755,123 | April 1, 2019 | June 30, 2028 | DESHPANDE, DEEPAK A | reporter.nih.gov |
| Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,707,951 | April 1, 2023 | March 31, 2027 | SHEU, SHEY-SHING | reporter.nih.gov |
| Training Grant in Cellular, Biochemical and Molecular Sciences | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,706,564 | July 1, 2022 | June 30, 2027 | MERRY, DIANE E | reporter.nih.gov |
| BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | NIH | National Cancer Institute | 2021 to 2025 | $1,683,312 | December 1, 2019 | November 30, 2025 | EISCHEN, CHRISTINE M. | reporter.nih.gov |
| Mechanisms of contractile dysfunction in the obstructed bladder: Role of desmin and vimentin | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,656,768 | September 15, 2022 | May 31, 2027 | ETTICKAN, BOOPATHI | reporter.nih.gov |
| Specialized Tools and Auto-updatable Scalable Interactive Databases to Study isomiRs, tRFs and rRFs in Human and Mouse | NIH | National Human Genome Research Institute | 2023 to 2025 | $1,645,404 | August 2, 2023 | May 31, 2027 | RIGOUTSOS, ISIDORE | reporter.nih.gov |
| The Role of m6A-RNA Methylation in Memory Formation and Recall and Its Modulation and Influence on Long-Term Outcomes as a Consequence of Early Life Lead Exposure | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,641,451 | June 15, 2023 | April 30, 2028 | SCHNEIDER, JAY S | reporter.nih.gov |
| Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy | NIH | National Cancer Institute | 2021 to 2024 | $1,628,112 | July 1, 2020 | June 30, 2025 | IOZZO, RENATO V. | reporter.nih.gov |
| Twice reading of RNA by direct nanopore sequencing | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,623,794 | May 1, 2024 | February 29, 2028 | HOU, YA-MING | reporter.nih.gov |
| miR-21 regulation of autoreactive B cell and lupus nephritis development | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,615,554 | July 18, 2022 | June 30, 2027 | RAHMAN, ZIAUR | reporter.nih.gov |
| IRF7-mediated development of autoreactive B cells and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,608,987 | June 23, 2021 | May 31, 2027 | RAHMAN, ZIAUR | reporter.nih.gov |
| Regulation of the Cell Death Program by DFNA5 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,591,114 | January 1, 2019 | November 30, 2024 | ALNEMRI, EMAD S | reporter.nih.gov |
| Targeting Adiponectin for Cardioprotection in the Ischemic Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,574,916 | May 1, 2010 | November 30, 2025 | MA, XIN-LIANG | reporter.nih.gov |
| Investigating a new vulnerability in oral squamous cell carcinoma | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $1,569,303 | July 1, 2023 | April 30, 2028 | EISCHEN, CHRISTINE M. | reporter.nih.gov |
| DC-subset-tailored vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,560,000 | June 17, 2020 | May 31, 2026 | IGYARTO, BOTOND Z | reporter.nih.gov |
| IL-37: a novel regulator of inflammation in CNS autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,560,000 | March 11, 2021 | February 28, 2027 | ROSTAMI, A.M. | reporter.nih.gov |
| Function and regulation of constitutive protein translation in platelets | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,560,000 | September 1, 2021 | May 31, 2026 | GOLDFINGER, LAWRENCE E | reporter.nih.gov |
| ThGM Cells in CNS Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,560,000 | July 12, 2021 | June 30, 2027 | ROSTAMI, A.M. | reporter.nih.gov |
| Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,548,300 | January 1, 2020 | December 31, 2026 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| Role of IL-7R in CNS autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,548,300 | December 1, 2020 | November 30, 2026 | ROSTAMI, A.M. | reporter.nih.gov |
| Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,548,300 | March 1, 2020 | February 28, 2027 | ROSTAMI, A.M. | reporter.nih.gov |
| Role of HIF-1 in Intervertebral Disc Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,543,168 | August 1, 2008 | September 19, 2024 | RISBUD, MAKARAND V | reporter.nih.gov |
| Novel mechanisms regulating protein interaction and pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,542,406 | December 15, 2019 | November 30, 2023 | DALVA, MATTHEW B | reporter.nih.gov |
| Extracellular mechanism regulating synaptic function and pain plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,533,165 | September 1, 2019 | January 8, 2024 | DALVA, MATTHEW B | reporter.nih.gov |
| Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,520,640 | January 1, 2010 | November 30, 2025 | SHEU, SHEY-SHING | reporter.nih.gov |
| Tissue Damage-Driven Squamous Cell Carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $1,470,745 | January 1, 2021 | January 30, 2025 | SOUTH, ANDREW | reporter.nih.gov |
| Targeted therapies in cutaneous melanoma | NIH | National Cancer Institute | 2021 to 2024 | $1,448,655 | July 14, 2014 | May 31, 2026 | APLIN, ANDREW ERIC | reporter.nih.gov |
| Regulation of Axonal Transport At Branch Junctions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,418,762 | April 1, 2020 | March 31, 2026 | MA, LE | reporter.nih.gov |
| E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,409,237 | September 1, 2022 | May 31, 2027 | SHARMA, PAWAN | reporter.nih.gov |
| Integration of epigenetic and non-coding RNA mechanism in leukemia | NIH | National Cancer Institute | 2021 to 2024 | $1,402,421 | July 1, 2023 | June 30, 2025 | MEYER, SARA E | reporter.nih.gov |
| Stress adaptation in obesity-associated pancreatic cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,402,420 | July 1, 2023 | June 30, 2025 | GRABOCKA, ELDA | reporter.nih.gov |
| Development of Best-in-Class Pol-Theta Inhibitors | NIH | National Cancer Institute | 2024 to 2025 | $1,394,665 | April 1, 2024 | March 31, 2029 | POMERANTZ, RICHARD T | reporter.nih.gov |
| Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,375,123 | February 1, 2025 | November 30, 2028 | PERA, TONIO | reporter.nih.gov |
| Novel Mechanisms and Regulation of Mammalian Double-Strand Break Repair | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,371,884 | January 1, 2024 | December 31, 2028 | POMERANTZ, RICHARD T | reporter.nih.gov |
| Discovery of Gram-negative permeable chemical probes for tRNA methylation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,368,444 | February 1, 2019 | January 31, 2025 | HOU, YA-MING | reporter.nih.gov |
| Defining the Role of West Nile Virus-Host Protein Interactions in Evading Antiviral Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,364,184 | July 1, 2019 | June 30, 2025 | RAMAGE, HOLLY | reporter.nih.gov |
| Mechanism of Viral Genome Delivery into Cells | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,363,775 | June 1, 2021 | September 28, 2023 | CINGOLANI, GINO | reporter.nih.gov |
| Role of the TE-cGAS-STING pathway in C9orf72-ALS/FTD pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,360,696 | September 18, 2024 | August 31, 2029 | TROTTI, DAVIDE | reporter.nih.gov |
| Pathogenesis of Inflammation-driven Intervertebral Disc Herniation: The Role of Syndecan 4 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,355,242 | April 1, 2019 | January 31, 2025 | RISBUD, MAKARAND V | reporter.nih.gov |
| Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,348,776 | August 1, 2020 | July 31, 2025 | WANG, BIN | reporter.nih.gov |
| Model Development for Prediction of Surgical Outcome in Temporal Lobe Epilepsy Patients: Incorporation of the Correlation between Post-Surgical Reorganization Phenotypes and Pre-Surgical Data | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,337,292 | July 1, 2019 | March 31, 2025 | TRACY, JOSEPH I. | reporter.nih.gov |
| Microbubble Cavitation for Improving Hepatocellular Carcinoma Radioembolization | NIH | National Cancer Institute | 2021 to 2024 | $1,332,481 | December 11, 2019 | November 30, 2025 | EISENBREY, JOHN | reporter.nih.gov |
| Determining the role of AR transcriptional function in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,320,516 | September 20, 2019 | July 31, 2025 | MERRY, DIANE E | reporter.nih.gov |
| The role of the AR interactome in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,317,299 | May 15, 2018 | April 30, 2028 | MERRY, DIANE E | reporter.nih.gov |
| Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone | NIH | National Institute on Aging | 2021 to 2024 | $1,284,307 | September 30, 2020 | June 30, 2026 | WANG, BIN | reporter.nih.gov |
| 2D and 3D Contrast-enhanced Ultrasound Evaluation of Chemoembolization. | NIH | National Cancer Institute | 2024 to 2025 | $1,270,432 | March 23, 2016 | July 31, 2029 | EISENBREY, JOHN | reporter.nih.gov |
| Replication stress in hematopoiesis and lymphomagenesis | NIH | National Cancer Institute | 2021 to 2023 | $1,266,867 | December 1, 2018 | November 30, 2025 | EISCHEN, CHRISTINE M. | reporter.nih.gov |
| The role of endogenous low molecular weight mineralization inhibitors in spine health | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,265,415 | February 1, 2024 | November 30, 2028 | VAN DE WETERING, KOEN | reporter.nih.gov |
| Mitochondrial Calcium Uniporter in Signaling and Dynamics | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,265,328 | September 15, 2023 | June 30, 2027 | HAJNOCZKY, GYORGY | reporter.nih.gov |
| Role of tRNA- and rRNA-derived RNAs in acute lung injury | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,253,912 | September 1, 2024 | May 31, 2028 | KIRINO, YOHEI | reporter.nih.gov |
| Regulation of Mutationally Activated Gq/11 | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,248,000 | April 1, 2021 | January 31, 2026 | WEDEGAERTNER, PHILIP B | reporter.nih.gov |
| A Next-Generation Nucleoside Prodrug for Diffuse Large B-Cell Lymphoma | NIH | National Cancer Institute | 2024 to 2025 | $1,247,192 | December 18, 2023 | November 30, 2028 | POMERANTZ, RICHARD T | reporter.nih.gov |
| Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,239,324 | April 1, 2019 | March 31, 2024 | SMEYNE, RICHARD J | reporter.nih.gov |
| Relevance of mitochondrial calcium uniporter for mitochondrial myopathy | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,235,520 | September 1, 2023 | August 31, 2027 | SEIFERT, ERIN | reporter.nih.gov |
| Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments | NIH | National Cancer Institute | 2021 to 2022 | $1,221,333 | July 1, 2018 | August 31, 2025 | SIMONE, NICOLE L | reporter.nih.gov |
| Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,174,373 | March 15, 2020 | February 28, 2026 | CHOI, JASON CHEOL | reporter.nih.gov |
| Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | September 1, 2015 | November 30, 2024 | MA, XIN-LIANG | reporter.nih.gov |
| How chlamydia generates cytoskeletal scaffolds and their role during infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,170,000 | January 22, 2019 | December 31, 2024 | PAUMET, FABIENNE MICHELLE | reporter.nih.gov |
| Early life exposures and chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | April 1, 2020 | February 28, 2025 | ROMAN, JESSE | reporter.nih.gov |
| Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,170,000 | April 1, 2021 | March 31, 2024 | GUO, LIN | reporter.nih.gov |
| Elucidating the roles for discrete actin filaments in maintenance of organelle and cellular homeostasis | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,170,000 | August 21, 2023 | July 31, 2028 | CHAKRABARTI, RAJARSHI | reporter.nih.gov |
| Single cell analysis of healthy and diseased temporomandibular joint synovial fluid | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $1,169,990 | September 1, 2024 | August 31, 2026 | TOMLINSON, RYAN | reporter.nih.gov |
| Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,161,698 | March 1, 2022 | March 31, 2027 | NEVALAINEN, MARJA T | reporter.nih.gov |
| Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,161,037 | April 1, 2024 | March 31, 2028 | DESHPANDE, DEEPAK A | reporter.nih.gov |
| Endogenous suppression of integrin signaling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,142,590 | August 1, 2013 | June 30, 2025 | NAIK, ULHAS P | reporter.nih.gov |
| Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,141,192 | December 26, 2023 | November 30, 2028 | ALIZADEH, MAHDI | reporter.nih.gov |
| Herbal and Dietary Supplement Induced Liver Injury in the U.S. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,136,701 | September 30, 2008 | July 31, 2028 | HALEGOUA-DEMARZIO, DINA | reporter.nih.gov |
| Mechanisms of RNA-DNA repair | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,132,044 | April 8, 2020 | March 31, 2024 | POMERANTZ, RICHARD T | reporter.nih.gov |
| RNA-based therapeutics for hemostasis and thrombosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,091,998 | May 1, 2024 | April 30, 2026 | GOLDFINGER, LAWRENCE E | reporter.nih.gov |
| WNT pathway-driven anti-estrogen therapy resistance in breast cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,087,240 | December 1, 2022 | April 30, 2028 | RUI, HALLGEIR | reporter.nih.gov |
| Regulation of homotypic fusion by Chlamydia | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,083,110 | February 7, 2024 | December 31, 2028 | PAUMET, FABIENNE MICHELLE | reporter.nih.gov |
| Mechanism for post-transcriptional gene regulation by Ribothrypsis | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,079,850 | July 1, 2023 | March 31, 2028 | IBRAHIM, FADIA FAYEZ | reporter.nih.gov |
| Crosstalk between DNA repair pathways in repeat instability | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,075,966 | February 1, 2023 | December 31, 2026 | PLUCIENNIK, ANNA | reporter.nih.gov |
| Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,067,829 | March 1, 2024 | February 29, 2028 | SEIFERT, ERIN | reporter.nih.gov |
| Deciphering the role of NELFE in modulating MYC signaling in HCC | NIH | National Cancer Institute | 2023 to 2025 | $1,061,371 | July 10, 2023 | June 30, 2028 | DANG, HIEN T. | reporter.nih.gov |
| Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $1,058,781 | June 1, 2021 | August 31, 2026 | VINOGRADSKIY, YEVGENIY | reporter.nih.gov |
| Breastfeeding Education Support Tool for Baby | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,055,221 | August 1, 2024 | July 31, 2029 | SHORT, VANESSA L | reporter.nih.gov |
| The Role of IL-15 in Cutaneous T-cell Lymphoma Progression | NIH | National Cancer Institute | 2023 to 2025 | $1,052,708 | July 20, 2023 | June 30, 2028 | MISHRA, ANJALI | reporter.nih.gov |
| Statistical Methods For Quantitative Immunohistochemistry Biomarkers | NIH | National Cancer Institute | 2021 to 2023 | $1,052,412 | February 1, 2019 | January 31, 2026 | CHERVONEVA, INNA | reporter.nih.gov |
| Regulation of Platelet Reactivity by S1P Signaling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,046,202 | July 1, 2019 | June 30, 2024 | NAIK, ULHAS P | reporter.nih.gov |
| Contribution of astrocytes to mutant FUS-linked Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,023,750 | May 15, 2019 | April 30, 2025 | PASINELLI, PIERA | reporter.nih.gov |
| NGF-TrkA Signaling in Load-Induced Bone Formation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,015,872 | April 1, 2019 | January 31, 2026 | TOMLINSON, RYAN | reporter.nih.gov |
| Molecular and cellular mechanisms that underlie synaptic maturation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,009,050 | September 15, 2019 | July 31, 2025 | MOSCA, TIMOTHY J. | reporter.nih.gov |
| Regulation of inositol trisphosphate receptors | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $965,404 | January 1, 2020 | December 31, 2024 | JOSEPH, SURESH K | reporter.nih.gov |
| Non-canonical MAPK signaling in yeast | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $964,080 | August 15, 2016 | August 31, 2025 | WINTER, EDWARD P | reporter.nih.gov |
| ASK1 a novel regulator of platelet function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $954,024 | April 1, 2019 | March 31, 2024 | NAIK, ULHAS P | reporter.nih.gov |
| Modeling network dynamics of cardiac right atrial ganglionic plexus to enable in silico testing of vagal neurostimulation strategies | NIH | Office of the Director, National Institutes of Health | 2021 | $941,588 | September 15, 2020 | September 14, 2024 | VADIGEPALLI, RAJANIKANTH | reporter.nih.gov |
| (11) Diet Modification to Augment Radiation for Breast Cancer Brain Metastases | NIH | National Cancer Institute | 2021 to 2022 | $940,563 | July 1, 2018 | June 30, 2025 | SIMONE, NICOLE L | reporter.nih.gov |
| Non-canonical functions of chromatin insulators and Polycomb-group proteins | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $936,000 | September 14, 2020 | June 30, 2025 | JAYNES, JAMES B | reporter.nih.gov |
| Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $935,793 | August 1, 2019 | June 30, 2024 | PENN, RAYMOND B. | reporter.nih.gov |
| The AR N/C interaction in SBMA - Mechanistic role and therapeutic potential | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $932,374 | May 15, 2018 | February 29, 2024 | MERRY, DIANE E | reporter.nih.gov |
| Molecular function of extracellular vimentin in regulating the response to lens wounding | NIH | National Eye Institute | 2024 to 2025 | $932,285 | April 1, 2024 | March 31, 2029 | WALKER, JANICE LYNN | reporter.nih.gov |
| Characterization of cocaine induced signaling pathways that enhances HIV transcription | NIH | National Institute on Drug Abuse | 2021 to 2023 | $916,120 | September 1, 2017 | April 30, 2026 | TYAGI, MUDIT | reporter.nih.gov |
| Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy | NIH | National Cancer Institute | 2021 to 2022 | $860,372 | August 1, 2020 | September 30, 2022 | LU, BO | reporter.nih.gov |
| The Role of the AR Interactome in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $858,540 | May 15, 2018 | February 29, 2024 | MERRY, DIANE E | reporter.nih.gov |
| Cell-Contact Mediated Mechanisms Assembling Synapses | NIH | National Institute on Drug Abuse | 2021 to 2022 | $848,154 | August 1, 2007 | June 30, 2023 | DALVA, MATTHEW B | reporter.nih.gov |
| Hypercalciuria and Abnormal Bone in the Genetic Hypercalciuric Stone-Forming Rats | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $841,498 | April 1, 2024 | January 31, 2029 | LI, QIAOLI | reporter.nih.gov |
| OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System | NIH | National Cancer Institute | 2025 | $789,068 | June 1, 2021 | May 31, 2027 | BADR, HODA J. | reporter.nih.gov |
| Neurodegeneration and Microvascular Damage in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $780,000 | June 15, 2019 | March 31, 2025 | HONGPAISAN, JARIN | reporter.nih.gov |
| Mechanism for feedback regulation of G protein-coupled receptor signaling in platelets | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $780,000 | August 15, 2019 | May 31, 2024 | MA, PEISONG | reporter.nih.gov |
| The Role of IL-II in the development of autoimmune response in multiple sclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $780,000 | July 11, 2018 | June 30, 2023 | MARKOVIC-PLESE, SILVA | reporter.nih.gov |
| Membrane trafficking in innate immunity to bacterial pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $780,000 | September 14, 2018 | August 31, 2024 | MANTEGAZZA, ADRIANA RITA | reporter.nih.gov |
| Platelets as regulator of non-neurological complications of ischemic stroke | NIH | National Heart, Lung, and Blood Institute | 2025 | $779,952 | June 15, 2025 | March 31, 2029 | NAIK, ULHAS P | reporter.nih.gov |
| (PQ5) Relevance of VDAC2 heterogeneity for hepatic tumor growth and targeting | NIH | National Cancer Institute | 2021 to 2022 | $778,766 | May 22, 2018 | July 31, 2024 | HAJNOCZKY, GYORGY | reporter.nih.gov |
| Integrin-mediated mechanisms of prostate cancer progression | NIH | National Cancer Institute | 2021 to 2022 | $777,452 | July 15, 2018 | June 30, 2025 | LANGUINO, LUCIA R. | reporter.nih.gov |
| Structure and Function of DNA Polymerase Theta | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $775,796 | February 15, 2019 | January 31, 2024 | POMERANTZ, RICHARD T | reporter.nih.gov |
| Thomas Jefferson University Hospital Clinical Site for HEAL NOWS Pharmacologic Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $769,580 | September 17, 2021 | August 31, 2026 | KRAFT, WALTER K | reporter.nih.gov |
| Using ultrasound and microbubbles to augment antibiotic efficacy against periprosthetic joint infections | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $769,390 | August 11, 2025 | July 31, 2030 | DELANEY, LAUREN JO | reporter.nih.gov |
| Leber Congenital Amaurosis 8 models and pathogenic mechanisms | NIH | National Eye Institute | 2021 to 2022 | $756,599 | September 8, 2020 | February 29, 2024 | CHO, SEO-HEE | reporter.nih.gov |
| Molecular composition of the mitochondrial calcium uniporter and cardiac pathophysiology | NIH | National Heart, Lung, and Blood Institute | 2021 | $749,269 | May 1, 2018 | February 28, 2023 | HAJNOCZKY, GYORGY | reporter.nih.gov |
| Vevo 3100 ultrasound scanner and PV loop system | NIH | Office of the Director, National Institutes of Health | 2021 | $746,509 | August 1, 2021 | July 31, 2022 | FORSBERG, FLEMMING | reporter.nih.gov |
| Molecular mechanisms of Werner syndrome helicase in genome stability and aging | NIH | National Institute on Aging | 2023 to 2025 | $742,017 | January 1, 2021 | January 31, 2027 | SONIAT, MICHAEL | reporter.nih.gov |
| Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $741,000 | April 1, 2021 | March 31, 2026 | GUO, LIN | reporter.nih.gov |
| Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal Infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $739,530 | September 10, 2021 | August 31, 2025 | DELANEY, LAUREN JO | reporter.nih.gov |
| FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma | NIH | National Cancer Institute | 2021 to 2022 | $733,590 | June 1, 2012 | January 31, 2025 | APLIN, ANDREW ERIC | reporter.nih.gov |
| Examining the function of biological sex specific genes: the NLGN4s | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $708,124 | May 15, 2018 | June 30, 2023 | DALVA, MATTHEW B | reporter.nih.gov |
| Pathophysiologic roles of protein-protein interactions at excitatory synapses and their modifications in schizophrenia | NIH | National Institute of Mental Health | 2025 | $706,404 | December 1, 2024 | November 30, 2029 | HAHN, CHANG-GYU | reporter.nih.gov |
| In Vivo Model of Human Enthesis Regeneration | NIH | National Institute on Aging | 2021 to 2023 | $701,085 | September 1, 2019 | June 30, 2025 | MCBEATH, ROWENA | reporter.nih.gov |
| Sexually-Dimorphic Regulation of Sleep | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $682,500 | September 17, 2018 | July 31, 2024 | KOH, KYUNGHEE | reporter.nih.gov |
| Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy and association with pregnancy outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $678,809 | January 13, 2025 | December 31, 2029 | BOELIG, RUPSA CHAUDHURY | reporter.nih.gov |
| Effects of extracellular vesicles on miRNA activity in the skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $675,576 | August 1, 2018 | May 31, 2024 | MAHONEY, MY GEORGIA | reporter.nih.gov |
| Chromium in carcinogenesis and angiogenesis | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $674,880 | July 1, 2018 | June 30, 2025 | HE, JUN | reporter.nih.gov |
| Novel Treatments for PXE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $667,599 | May 7, 2018 | April 30, 2023 | LI, QIAOLI | reporter.nih.gov |
| Reducing Emergency Diabetes Care for Older African Americans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $665,586 | May 21, 2018 | September 30, 2023 | ROVNER, BARRY W. | reporter.nih.gov |
| Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy | NIH | National Cancer Institute | 2021 to 2022 | $663,601 | June 1, 2021 | May 31, 2023 | VINOGRADSKIY, YEVGENIY | reporter.nih.gov |
| Dissection of the piRNA biogenesis pathway in germ cells | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $655,200 | August 1, 2013 | May 31, 2024 | KIRINO, YOHEI | reporter.nih.gov |
| The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $653,648 | February 3, 2017 | January 31, 2023 | MAZO, ALEXANDER M | reporter.nih.gov |
| Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $628,845 | July 1, 2018 | March 31, 2023 | EISENBREY, JOHN | reporter.nih.gov |
| Dynamin-Related Protein Drp1 Regulates Cardiac Excitation-Contraction-Bioenergetics Coupling | NIH | National Heart, Lung, and Blood Institute | 2021 | $628,675 | January 1, 2018 | November 30, 2023 | SHEU, SHEY-SHING | reporter.nih.gov |
| Noninvasive Portal Pressure Measurements in Children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $624,631 | September 1, 2018 | August 31, 2025 | FORSBERG, FLEMMING | reporter.nih.gov |
| Dysregulated Adiponectin Transmembrane Signaling in Diabetic Coronary Vascular Injury and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 | $624,478 | February 1, 2022 | July 31, 2022 | WANG, YAJING | reporter.nih.gov |
| G Protein Regulation of Golgi Structure and Function | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $624,000 | May 7, 2019 | August 31, 2024 | WEDEGAERTNER, PHILIP B | reporter.nih.gov |
| Training Program in Cancer Biology | NIH | National Cancer Institute | 2021 to 2023 | $620,257 | September 19, 2019 | August 31, 2025 | LANGUINO, LUCIA R. | reporter.nih.gov |
| Structural-functional zoning of the mitochondrion in cardiac Ca2+, ROS, and energetics regulation | NIH | National Heart, Lung, and Blood Institute | 2021 | $611,797 | August 15, 2018 | April 30, 2024 | SHEU, SHEY-SHING | reporter.nih.gov |
| Solute Transporters and Retinal Health | NIH | National Eye Institute | 2025 | $595,302 | April 1, 2025 | March 31, 2030 | PHILP, NANCY JEAN | reporter.nih.gov |
| Multiscale Model of the Vagal Outflow to the Heart | NIH | National Heart, Lung, and Blood Institute | 2021 | $579,602 | April 10, 2017 | March 31, 2023 | SCHWABER, JAMES | reporter.nih.gov |
| Short inhibitory RNAs in platelet and megakaryocyte function | NIH | National Heart, Lung, and Blood Institute | 2025 | $552,413 | April 1, 2025 | January 31, 2029 | GOLDFINGER, LAWRENCE E | reporter.nih.gov |
| Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 | $541,789 | December 15, 2017 | November 30, 2023 | DESHPANDE, DEEPAK A | reporter.nih.gov |
| The pathogenic relationship between neuronal activity and C9orf72-linked neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $536,869 | September 15, 2020 | August 31, 2025 | HAEUSLER, AARON RAYMOND | reporter.nih.gov |
| Structural and dynamic analysis of GRK interaction with G protein-coupled receptors | NIH | National Heart, Lung, and Blood Institute | 2021 | $528,803 | April 1, 2018 | March 31, 2023 | BENOVIC, JEFFREY L | reporter.nih.gov |
| Regulation of G protein-coupled receptor signaling and trafficking | NIH | National Institute of General Medical Sciences | 2021 | $507,000 | August 1, 2017 | July 31, 2023 | BENOVIC, JEFFREY L | reporter.nih.gov |
| Alcohol Tissue Injury | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $500,589 | July 1, 1986 | June 30, 2024 | HOEK, JOANNES B | reporter.nih.gov |
| New mechanisms of acquired resistance to EGFR-TKIs in Non-small-cell lung cancer | NIH | National Cancer Institute | 2021 to 2022 | $498,000 | February 1, 2020 | January 31, 2024 | HE, JUN | reporter.nih.gov |
| Structural and Functional Studies on Proton-activated Chloride (PAC) Channel | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $490,528 | August 15, 2022 | February 28, 2027 | RUAN, ZHENG | reporter.nih.gov |
| The Role of Sensory Predictions in Updating Perception and Action | NSF | Division of Behavioral and Cognitive Sciences | 2025 | $488,904 | August 1, 2025 | July 31, 2028 | Amanda S Therrien | nsf.gov |
| Investigating and targeting NSD2 mutation-driven leukemia transformation | NIH | National Cancer Institute | 2025 | $484,405 | September 1, 2025 | August 31, 2030 | LI, JIANPING | reporter.nih.gov |
| Olfactory neuroepithelial cell derived induced neurons for study of schizophrenia | NIH | National Institute of Mental Health | 2023 | $475,813 | September 1, 2023 | August 31, 2025 | HAHN, CHANG-GYU | reporter.nih.gov |
| Optimizing Ultrasound Enhanced Delivery of Therapeutics | NIH | National Cancer Institute | 2022 to 2023 | $474,215 | August 25, 2016 | January 31, 2025 | FORSBERG, FLEMMING | reporter.nih.gov |
| Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness | NIH | National Cancer Institute | 2021 to 2022 | $473,469 | December 1, 2019 | January 2, 2022 | RODRIGUEZ-BRAVO, VERONICA | reporter.nih.gov |
| Target Validation for I-BET151-Induced Differentiation in the African Trypanosome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $459,483 | February 1, 2021 | July 31, 2023 | DEBLER, ERIK | reporter.nih.gov |
| Integration of platelets and coagulation to maintain hemostasis in vivo | NIH | National Heart, Lung, and Blood Institute | 2025 | $457,514 | September 5, 2025 | May 31, 2029 | STALKER, TIMOTHY J. | reporter.nih.gov |
| Mechanisms of gene regulation mediated by human-specific SVA transposons | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $455,000 | July 1, 2020 | August 31, 2022 | TRIZZINO, MARCO | reporter.nih.gov |
| Community-informed approaches to the escalating presence of xylazine in opioids | NIH | National Institute on Drug Abuse | 2023 to 2024 | $447,120 | May 1, 2023 | April 30, 2026 | REED, MEGAN | reporter.nih.gov |
| The tRNA pool in C9-ALS/FTD | NIH | National Institute on Aging | 2023 to 2024 | $444,696 | April 1, 2023 | March 31, 2026 | HOU, YA-MING | reporter.nih.gov |
| Identification of epigenetic marks underlying exercise-induced neuroprotection in Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $443,794 | June 15, 2022 | May 31, 2025 | SMEYNE, RICHARD J | reporter.nih.gov |
| Assessing fentanyl test strip use accuracy and fentanyl presence in the non-heroin drug supply | NIH | National Institute on Drug Abuse | 2023 to 2024 | $441,826 | May 1, 2023 | April 30, 2026 | REED, MEGAN | reporter.nih.gov |
| Synovial Fluid and Joint Sepsis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $440,970 | August 1, 2017 | May 31, 2023 | HICKOK, NOREEN J | reporter.nih.gov |
| IFN-I production in vivo for resistance to acute disseminating viral Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $437,417 | December 1, 2014 | August 31, 2022 | SIGAL, LUIS J | reporter.nih.gov |
| Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $430,932 | April 15, 2021 | March 31, 2024 | MARKOVIC-PLESE, SILVA | reporter.nih.gov |
| Synaptic Dysfunction and Energy Failure in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $429,140 | June 15, 2022 | March 31, 2023 | ZHANG, HUI | reporter.nih.gov |
| Role of Toll-like receptor-induced short non-coding RNAs in innate immune response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,000 | December 4, 2020 | November 30, 2023 | KIRINO, YOHEI | reporter.nih.gov |
| A System to Study Salmonella Typhi Infection and Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,000 | March 1, 2021 | February 29, 2024 | ALUGUPALLI, KISHORE R | reporter.nih.gov |
| Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,000 | June 2, 2021 | September 30, 2024 | SIGAL, LUIS J | reporter.nih.gov |
| Synergistic Interactions of SARs-CoV2 and environmental toxicants in Experimental Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $429,000 | July 1, 2021 | December 31, 2022 | SMEYNE, RICHARD J | reporter.nih.gov |
| CBF-1 role in regulating HIV reservoir in microglial cells | NIH | National Institute of Mental Health | 2022 to 2023 | $429,000 | June 1, 2022 | May 31, 2026 | TYAGI, MUDIT | reporter.nih.gov |
| Role of rRNA-derived short non-coding RNAs in innate immune response | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $429,000 | February 7, 2022 | January 31, 2025 | KIRINO, YOHEI | reporter.nih.gov |
| A role for extracellular vesicles in neuroinflammation associated to frontotemporal dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $429,000 | May 15, 2022 | October 31, 2024 | TROTTI, DAVIDE | reporter.nih.gov |
| Sleep induction by repetitive mechanosensory stimulation. | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $429,000 | September 1, 2022 | August 31, 2025 | KOH, KYUNGHEE | reporter.nih.gov |
| Skin-homing Group-1 innate lymphoid cells in viral defense | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $429,000 | November 10, 2022 | October 31, 2025 | DEBES, GUDRUN PHILOMENA | reporter.nih.gov |
| Endogenous single-stranded RNA ligands for endosomal Toll-like receptors | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $429,000 | August 22, 2023 | July 31, 2026 | KIRINO, YOHEI | reporter.nih.gov |
| Neuroprotection by the GUCY2C gut-brain axis in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $429,000 | September 1, 2023 | August 31, 2025 | WALDMAN, SCOTT A | reporter.nih.gov |
| Therapeutic strategies to rescue metabolic deficiencies in spinal and bulbar muscular atrophy | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $429,000 | September 15, 2023 | August 31, 2025 | MERRY, DIANE E | reporter.nih.gov |
| Targeting miRNA-loaded exosomes to HNSCC with Dsg2-directed scFv fusion proteins | NIH | National Institute of Dental & Craniofacial Research | 2024 | $429,000 | September 15, 2024 | September 14, 2026 | MAHONEY, MY GEORGIA | reporter.nih.gov |
| The role of CXCL10 expressing B cells in skin inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $429,000 | June 6, 2024 | April 30, 2026 | DEBES, GUDRUN PHILOMENA | reporter.nih.gov |
| Investigating the role of mitochondrial function in driving lens fibrotic disease | NIH | National Eye Institute | 2024 | $429,000 | June 1, 2024 | May 31, 2026 | WALKER, JANICE LYNN | reporter.nih.gov |
| Molecular pathways linking frontotemporal dementia and circadian dysfunction | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $429,000 | March 7, 2024 | August 31, 2026 | KOH, KYUNGHEE | reporter.nih.gov |
| Assessment of placenta vascularization development using contrast-enhanced ultrasound | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $429,000 | September 16, 2024 | August 31, 2026 | NAM, KIBO | reporter.nih.gov |
| Evaluation of Uterine Fibroids by Contrast Enhanced Ultrasound (CEUS) and Subharmonic-Aided Pressure Estimation (SHAPE) Pre and Post Uterine Artery Embolization (UAE) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $429,000 | August 1, 2024 | July 31, 2027 | MACHADO, PRISCILLA | reporter.nih.gov |
| The mechanism and role of androgen receptor Serine 16 phosphorylation in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $429,000 | July 1, 2024 | June 30, 2026 | MERRY, DIANE E | reporter.nih.gov |
| Assessment of Uterine Cervical Insufficiency using 4D Contrast-Enhanced Ultrasound | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $429,000 | September 16, 2024 | August 31, 2026 | NAM, KIBO | reporter.nih.gov |
| Cell type specific analysis of Src kinase-NMDA receptor complexes in schizophrenia | NIH | National Institute of Mental Health | 2024 | $429,000 | August 1, 2024 | July 31, 2026 | HAHN, CHANG-GYU | reporter.nih.gov |
| Biogenesis and function of cyclic phosphate-containing RNAs | NIH | National Institute of General Medical Sciences | 2025 | $429,000 | February 8, 2025 | December 31, 2029 | KIRINO, YOHEI | reporter.nih.gov |
| The Role of Alzheimer's Disease Risk Genes in Neural Function, Degeneration, and Synapse Organization | NIH | National Institute on Aging | 2025 | $429,000 | January 15, 2025 | December 31, 2026 | MOSCA, TIMOTHY J. | reporter.nih.gov |
| Somatic instability of CAG repeats in spinal and bulbar muscular atrophy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $429,000 | May 15, 2025 | April 30, 2027 | MERRY, DIANE E | reporter.nih.gov |
| Assessing healthy breast tissue for evidence of ancestry-dependent molecular contributions to TNBC disparities | NIH | National Cancer Institute | 2023 | $413,815 | September 19, 2023 | August 31, 2025 | RIGOUTSOS, ISIDORE | reporter.nih.gov |
| Critical Role of Small Extracellular Vesicles in Diabetic Coronary Vascular Dysfunction and Diabetic Ischemic Heart Failure efforts. | NIH | National Heart, Lung, and Blood Institute | 2021 | $404,550 | July 5, 2021 | April 30, 2025 | WANG, YAJING | reporter.nih.gov |
| Ligand-Induced Recruitment of CAR-T Cells to Colorectal Cancers | NIH | National Cancer Institute | 2024 to 2025 | $401,115 | December 15, 2023 | November 30, 2026 | SNOOK, ADAM | reporter.nih.gov |
| Contrast-enhanced ultrasound evaluation of radioembolization treatment response | NIH | National Cancer Institute | 2025 | $401,115 | August 1, 2025 | July 31, 2027 | EISENBREY, JOHN | reporter.nih.gov |
| Vivarium Modernization with Digital Ventilated Cages to Enhance Research Capacity and Reproducibility, and Provide Cage Environment Monitoring for Improved Operational Efficiency and Animal Welfare | NIH | Office of the Director, National Institutes of Health | 2022 | $400,000 | August 1, 2022 | July 31, 2023 | TARASCHI, THEODORE F | reporter.nih.gov |
| Inspiring Undergraduate Student Training in Alzheimer's Research | NIH | National Institute on Aging | 2024 | $399,296 | April 15, 2024 | March 31, 2025 | ROVNER, BARRY W. | reporter.nih.gov |
| Detection of sentinel lymph nodes in female lower genital tract cancer patients with contrast-enhanced ultrasound imaging | NIH | National Cancer Institute | 2021 to 2022 | $397,469 | August 1, 2021 | July 31, 2024 | LIU, JI-BIN | reporter.nih.gov |
| A chatbot-powered G8 screening intervention to facilitate referrals to a comprehensive geriatric assessment among older adults with cancer | NIH | National Cancer Institute | 2021 to 2022 | $397,469 | August 1, 2021 | July 31, 2024 | WEN, KUANG-YI | reporter.nih.gov |
| Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma | NIH | National Cancer Institute | 2022 to 2023 | $397,469 | December 3, 2021 | May 31, 2025 | EISENBREY, JOHN | reporter.nih.gov |
| Enzyme Therapy for PXE: Breaking the Barrier of Ectopic Calcification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $396,924 | August 25, 2022 | July 31, 2025 | LI, QIAOLI | reporter.nih.gov |
| Serological and functional impact of COVID-19 vaccination on the maternal fetal unit and infant immunity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $395,922 | September 1, 2022 | August 31, 2025 | BOELIG, RUPSA CHAUDHURY | reporter.nih.gov |
| Role of Stx11 and STXBP2 in lytic granule exocytosis in health and disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $392,772 | January 25, 2017 | December 31, 2022 | GIRAUDO, CLAUDIO GUILLERMO | reporter.nih.gov |
| Pharmacologic Intervention for Ectopic Calcification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $392,476 | March 1, 2021 | February 29, 2024 | LI, QIAOLI | reporter.nih.gov |
| Acoustic Droplet Initiated Radiosensitivity of Hepatocellular Carcinoma | NIH | National Cancer Institute | 2023 to 2024 | $390,176 | April 1, 2023 | March 31, 2026 | EISENBREY, JOHN | reporter.nih.gov |
| Development of a single-dose rabies virus vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $390,000 | November 22, 2016 | October 31, 2022 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| Mechanisms of GM-CSF effect in CNS autoimmune demyelination | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $390,000 | December 15, 2016 | November 30, 2023 | ROSTAMI, A.M. | reporter.nih.gov |
| Adipose tissue metabolic changes in chronic kidney disease and its contribution to adiponectin resistance and post-transplant diabetes mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $390,000 | July 21, 2017 | May 31, 2023 | MARTINEZ CANTARIN, MARIA PAULA | reporter.nih.gov |
| Exploring 3Dpol for RNA sequencing in real time | NIH | National Human Genome Research Institute | 2021 to 2022 | $390,000 | May 18, 2020 | April 30, 2024 | HOU, YA-MING | reporter.nih.gov |
| Supplement -- The pathogenic relationship between neuronal activity and C9orf72-linked neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $390,000 | July 1, 2021 | June 30, 2022 | HAEUSLER, AARON RAYMOND | reporter.nih.gov |
| Elucidating the mechanisms underlying DNA double-strand break repair | NIH | National Institute of General Medical Sciences | 2025 | $390,000 | February 1, 2025 | December 31, 2029 | SONIAT, MICHAEL | reporter.nih.gov |
| Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $388,751 | September 1, 2018 | August 31, 2024 | SIGAL, LUIS J | reporter.nih.gov |
| A population-based approach to single CTC analysis in metastatic breast cancer outcome | NIH | National Cancer Institute | 2021 to 2022 | $386,661 | August 15, 2017 | July 31, 2024 | YANG, HUSHAN | reporter.nih.gov |
| Novel Molecular and Cellular Mechanisms for Osteoanabolic Action of Parathyroid Hormone | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $380,579 | April 1, 2019 | March 31, 2023 | WANG, BIN | reporter.nih.gov |
| Using human IPS cells to study fate, function and neurodegenerative disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $378,225 | April 1, 2012 | June 30, 2024 | IACOVITTI, LORRAINE | reporter.nih.gov |
| Epigenetic predisposition and pathogenic mechanisms of recessive dystrophic epidermolysis bullosa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $377,520 | August 1, 2022 | August 31, 2024 | IGOUCHEVA, OLGA | reporter.nih.gov |
| Characterization of ENTPD1 as a drug target in PXE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $377,520 | September 20, 2023 | September 19, 2025 | VAN DE WETERING, KOEN | reporter.nih.gov |
| Self-Concept of Neurodivergent Undergraduate Students in STEM | NSF | Education Capacity Building & Transformation Section | 2023 | $360,772 | October 1, 2023 | September 30, 2027 | Stephen R Podowitz-Thomas | nsf.gov |
| Guanylin GUCY2C axis in Colorectal Cancer Initiation | NIH | National Cancer Institute | 2021 | $357,970 | January 1, 2017 | December 31, 2022 | WALDMAN, SCOTT A | reporter.nih.gov |
| Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer | NIH | National Cancer Institute | 2021 | $357,405 | August 1, 2017 | July 31, 2023 | MCNAIR, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Gene Therapy for PXE: Breaking the Barrier of Ectopic Calcification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $356,928 | May 2, 2024 | April 30, 2027 | LI, QIAOLI | reporter.nih.gov |
| Optimice 100-Cage IVC System | NIH | Office of the Director, National Institutes of Health | 2025 | $347,945 | August 1, 2025 | July 30, 2026 | LATOURETTE, PHIL | reporter.nih.gov |
| Ursolic acid: a novel oral therapy for chronic stage of MS/EAE by both immunomodulation and neural repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $341,250 | June 1, 2017 | April 30, 2023 | ZHANG, GUANG-XIAN | reporter.nih.gov |
| Regulation of Nuclear Import Through Importin Alpha Isoforms | NIH | National Institute of General Medical Sciences | 2021 | $327,600 | March 1, 2018 | December 31, 2021 | CINGOLANI, GINO | reporter.nih.gov |
| Single cell analysis of healthy and diseased temporomandibular joint synovial fluid | NIH | National Institute of Dental & Craniofacial Research | 2022 | $326,310 | September 9, 2022 | August 31, 2024 | TOMLINSON, RYAN | reporter.nih.gov |
| Transcriptional Regulation by Epigenetic Factors | NIH | National Institute of General Medical Sciences | 2021 | $319,800 | August 1, 2005 | August 31, 2023 | MAZO, ALEXANDER M | reporter.nih.gov |
| Role of HIF-1 in intervertebral disc function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $312,002 | September 20, 2024 | September 30, 2025 | RISBUD, MAKARAND V | reporter.nih.gov |
| Exocytosis of Lytic granules | NIH | National Institute of General Medical Sciences | 2021 | $306,150 | June 1, 2017 | February 28, 2023 | GIRAUDO, CLAUDIO GUILLERMO | reporter.nih.gov |
| Migration and function of cutaneous B cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $304,104 | January 5, 2017 | December 31, 2022 | DEBES, GUDRUN PHILOMENA | reporter.nih.gov |
| IRES Track I: A U.S.-Ireland Partnership for an International Graduate Research Experience in Biopharmaceutical Processing | NSF | Office of International Science and Engineering | 2022 | $300,000 | December 1, 2021 | November 30, 2025 | Brent Chamberlain | nsf.gov |
| The role of IgM in the regulation of skin inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $284,670 | August 5, 2022 | January 31, 2024 | DEBES, GUDRUN PHILOMENA | reporter.nih.gov |
| Understanding layer-specific contributions to perception and learning in human cortex | NIH | National Eye Institute | 2025 | $249,000 | September 30, 2025 | August 31, 2028 | PERSICHETTI, ANDREW S | reporter.nih.gov |
| Deciphering the mechanisms of PARP1 activity in telomere integrity | NIH | National Institute of Environmental Health Sciences | 2021 | $248,999 | February 1, 2019 | February 11, 2022 | FOUQUEREL, ELISE | reporter.nih.gov |
| Automated Liquid Handler | NIH | Office of the Director, National Institutes of Health | 2022 | $247,215 | September 1, 2022 | August 31, 2024 | FORTINA, PAOLO M | reporter.nih.gov |
| Inflammation and plaque formation downstream of disrupted autophagy in Alzheimer's disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $246,246 | December 3, 2024 | November 30, 2027 | GOLDSMITH, JULIET | reporter.nih.gov |
| New Mechanism of Arsenic Carcinogenesis | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $245,026 | November 13, 2020 | March 31, 2023 | LIU, LING-ZHI | reporter.nih.gov |
| Aspirin for preeclampsia prevention: Pharmacodynamics and pharmacogenomics of platelet response and pregnancy outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $234,000 | April 1, 2020 | March 31, 2024 | BOELIG, RUPSA CHAUDHURY | reporter.nih.gov |
| Circulating immunoactive small RNAs in COPD as biomarkers. | NIH | National Heart, Lung, and Blood Institute | 2025 | $234,000 | September 1, 2025 | August 31, 2027 | SHIGEMATSU, MEGUMI HAMASAKI | reporter.nih.gov |
| The role of collagen VII in extracellular matrix protein secretion | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $227,518 | June 1, 2024 | January 30, 2025 | SOUTH, ANDREW | reporter.nih.gov |
| The Role of the GPR15-C10ORF99 Pathway in T cell Homing during Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $226,980 | February 1, 2025 | January 31, 2027 | KIM, SANGWON VINCENT | reporter.nih.gov |
| Protein therapeutics inspired by importins | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $215,341 | August 15, 2022 | July 31, 2024 | CINGOLANI, GINO | reporter.nih.gov |
| Clinical Pharmacology Training Program | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $203,582 | May 21, 2025 | April 30, 2030 | KRAFT, WALTER K | reporter.nih.gov |
| Function of HIV-1 Env cytoplasmic tail domain | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $197,995 | February 1, 2025 | January 31, 2027 | ROOT, MICHAEL JEFFREY | reporter.nih.gov |
| Stem cell origins of human fetal/neonatal B cell subsets | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $195,000 | May 5, 2020 | April 30, 2024 | MANSER, TIMOTHY L | reporter.nih.gov |
| Discovering new genes involved in protective T-cell responses through the generation of mice with targeted mutations | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $195,000 | June 1, 2020 | May 31, 2023 | SIGAL, LUIS J | reporter.nih.gov |
| A multiplex automatic autostainer at Jefferson | NIH | Office of the Director, National Institutes of Health | 2024 | $195,000 | September 1, 2024 | August 31, 2025 | YANG, HAIFENG | reporter.nih.gov |
| Parkinson's disease therapies targeting GUCY2C | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $179,442 | September 1, 2022 | October 31, 2025 | CHESLOW, LARA | reporter.nih.gov |
| A cell model of YARS2-associated childhood-onset mitochondrial disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $174,000 | February 1, 2023 | January 31, 2026 | HOU, YA-MING | reporter.nih.gov |
| 3/22 DPPOS Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $173,918 | August 15, 1994 | August 31, 2022 | FURLONG, KEVIN J. | reporter.nih.gov |
| LEAPS-MPS: Exploring the Utility of Bifunctional Reagents for the Visible Light-Mediated Synthesis of Heterocycles and Biologically Relevant Molecules | NSF | Chemistry Section | 2023 | $169,372 | September 1, 2023 | August 31, 2026 | John Milligan | nsf.gov |
| Biasing OGR1 signaling to optimizing PTH therapeutic effect | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $166,452 | February 1, 2020 | July 31, 2022 | WANG, BIN | reporter.nih.gov |
| Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells | NIH | National Cancer Institute | 2021 to 2022 | $156,000 | March 1, 2021 | February 29, 2024 | RAMIREZ, MARIA ISABEL | reporter.nih.gov |
| The malignant microenvironment in early cutaneous T-cell lymphoma | NIH | National Cancer Institute | 2021 to 2022 | $156,000 | August 1, 2021 | July 31, 2024 | NIKBAKHT, NEDA | reporter.nih.gov |
| Control of lipid droplet homeostasis by Chlamydia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $156,000 | July 1, 2021 | June 30, 2024 | PAUMET, FABIENNE MICHELLE | reporter.nih.gov |
| SIRT6 as a novel therapeutic target in aging and age-related osteoarthritis | NIH | National Institute on Aging | 2021 to 2022 | $156,000 | September 30, 2021 | November 30, 2023 | COLLINS, JOHN A | reporter.nih.gov |
| An animal model for cytomegalovirus-induced pathology in the developing retina | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $156,000 | February 1, 2022 | January 31, 2025 | SNYDER, CHRISTOPHER M | reporter.nih.gov |
| Mitostatin-evoked mitophagy for breast cancer inhibition | NIH | National Cancer Institute | 2023 to 2024 | $156,000 | June 5, 2023 | May 31, 2026 | IOZZO, RENATO V. | reporter.nih.gov |
| Developing tools for calcium imaging in ITPR2-linked liver pathogenesis | NIH | National Center for Advancing Translational Sciences | 2023 | $156,000 | September 1, 2023 | August 31, 2024 | HAJNOCZKY, GYORGY | reporter.nih.gov |
| Elucidating the relevance of BARD1-PLK1 interaction in PDAC and response to therapy | NIH | National Cancer Institute | 2023 to 2024 | $156,000 | July 14, 2023 | June 30, 2025 | JAIN, ADITI | reporter.nih.gov |
| Circulating tumor cell profiling for genomic contributors to racial disparity in metastatic prostate cancer | NIH | National Cancer Institute | 2024 | $156,000 | July 12, 2024 | June 30, 2026 | WANG, CHUN | reporter.nih.gov |
| Novel Therapeutic Strategies for Suppressing cGAS-STING Pathway in Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $156,000 | December 15, 2024 | November 30, 2026 | SCOPA, CHIARA | reporter.nih.gov |
| Characterization of Homotypic Fusion in Chlamydia muridarum | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $156,000 | July 14, 2025 | June 30, 2027 | WESOLOWSKI, JORDAN TYLER | reporter.nih.gov |
| Determining the cellular and nanoscale localization of Synaptotagmin VII | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $153,756 | December 5, 2022 | July 31, 2026 | CAIN, RACHEL | reporter.nih.gov |
| Contribution of Zranb3 to normal and stressed hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $151,718 | July 1, 2020 | June 30, 2024 | KUSHINSKY, SAUL | reporter.nih.gov |
| Mechanistic insight into oxidative stress-mediated genome instability | NIH | National Institute of General Medical Sciences | 2021 | $129,756 | August 1, 2021 | February 11, 2022 | FOUQUEREL, ELISE | reporter.nih.gov |
| Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $128,058 | January 1, 2021 | May 23, 2024 | BARTON, JOSHUA R | reporter.nih.gov |
| Targeting TEAD in melanoma drug-tolerant persister cells | NIH | National Cancer Institute | 2024 to 2025 | $98,512 | July 5, 2024 | July 4, 2026 | OTT, CONNOR | reporter.nih.gov |
| Uncovering the impact of oxidative stress on centromere integrity | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $98,512 | August 1, 2024 | July 31, 2026 | THOMPSON, LILY | reporter.nih.gov |
| Restoring Guanylin-Guanylate cyclase C Signaling to Prevent Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2022 | $95,324 | January 1, 2019 | December 31, 2022 | RAPPAPORT, JEFFREY | reporter.nih.gov |
| Regulation of Development by LRP4 at Drosophila Peripheral Synapses | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $94,446 | January 1, 2021 | December 31, 2023 | DEPEW, ALISON | reporter.nih.gov |
| Alcohol-associated liver disease facilitates lobule scale metabolic reprogramming to modulate regeneration | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $94,446 | September 21, 2022 | September 20, 2024 | MANCHEL, ALEXANDRA ROSE | reporter.nih.gov |
| Interrogation of TLR2 Inflammatory Signaling in AML | NIH | National Cancer Institute | 2022 to 2023 | $94,446 | September 1, 2022 | August 31, 2024 | LAWLER, MICHAEL | reporter.nih.gov |
| The Role of sEV-associated miR-146a in Tissue Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $94,446 | September 27, 2022 | September 26, 2024 | HILL, BRIANNA LEIGH | reporter.nih.gov |
| Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer | NIH | National Cancer Institute | 2021 | $93,163 | July 1, 2021 | January 2, 2022 | DOMINGO-DOMENECH, JOSEP MARIA | reporter.nih.gov |
| Inducing transcriptional reprogramming of leukemic B-cells by facilitating transcription factors binding to nascent decondensed chromatin | NIH | National Cancer Institute | 2021 to 2022 | $92,788 | May 1, 2021 | April 30, 2023 | DEMING, DAVID | reporter.nih.gov |
| Ultrasound-Sensitive Prophylaxis for Prevention of Post-Operative Infection in Spinal Fusion Surgery | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $86,325 | September 10, 2021 | August 31, 2022 | DELANEY, LAUREN JO | reporter.nih.gov |
| Regulation of cytoskeletal reorganization by a single effector during Chlamydia infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $75,660 | December 1, 2024 | November 30, 2026 | PAUMET, FABIENNE MICHELLE | reporter.nih.gov |
| Metabolic perturbations as a modifier of repeat-associated non-AUG translation in C9orf72-linked ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $46,036 | September 17, 2020 | September 16, 2022 | NELSON, ANDREW | reporter.nih.gov |
| The role of subjective values and dopamine availability in incentive-based motor learning | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $35,500 | August 1, 2025 | December 31, 2025 | WOOD, JONATHAN | reporter.nih.gov |
| 2024 ORS/PSRS 7th International Spine Research Symposium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $25,000 | July 19, 2024 | July 14, 2025 | RISBUD, MAKARAND V | reporter.nih.gov |
| 2021 ORS/PSRS 6th International Spine Research Symposium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $15,000 | August 1, 2022 | July 31, 2023 | RISBUD, MAKARAND V | reporter.nih.gov |
| Recruitment of transcriptional machinery following DNA replication | NIH | National Institute of General Medical Sciences | 2021 | $11,509 | December 1, 2018 | February 28, 2021 | FENSTERMAKER, TYLER KENNEDY | reporter.nih.gov |
| Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal Infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $4,813 | September 1, 2018 | September 9, 2021 | DELANEY, LAUREN JO | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 129 | $73,023,771 | 1 | $488,904 |
| 2024 | 156 | $72,487,657 | 1 | $11,274 |
| 2023 | 154 | $67,635,077 | 2 | $518,870 |
| 2022 | 182 | $79,195,354 | 1 | $300,000 |
| 2021 | 189 | $80,838,359 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 48 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 48 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 48 awards here |
Topics of its NIH awards
- Genetics
- Neurosciences
- Cancer
- Rare Diseases
- Clinical Research
- Biotechnology
- Brain Disorders
- Prevention
- Neurodegenerative
- Infectious Diseases
- Aging
- Translational Research
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.